Sunday, July 6, 2025
25 °c
Agartala
enewstime
No Result
View All Result
No Result
View All Result
enewstime
  • Advertising Policy
  • Contact Enewstime
  • Cookie Policy
  • Disclaimer
  • ENEWSTIME Homepage
  • Features
  • Latest Tenders
  • News
  • Privacy Policy
  • Tenders
  • Terms of Use
Home Health

Study shows diabetes drug may help treat prostate cancer

IANS by IANS
May 7, 2025
in Health
Study shows diabetes drug may help treat prostate cancer
34
VIEWS
Share on FacebookShare on Twitter

New Delhi, May 7 (IANS) Certain drugs used to treat type 2 diabetes can also be used to treat prostate cancer, according to a study.

Researchers from the Medical University of Vienna in Austria identified similarities in the mechanisms of diabetes and cancer.

They showed that the protein PPARγ (peroxisome proliferator-activated receptor gamma) — central to the regulation of metabolic processes — can also influence the growth of prostate cancer cells.

But PPARγ is already known to be a target of certain drugs including so-called thiazolidinediones such as pioglitazone, which are used to treat type 2 diabetes.

The findings “showed that the diabetes drug pioglitazone influences the activity of PPARγ and thus inhibits the growth behaviour and metabolism of tumour cells. Furthermore, initial results revealed that prostate cancer patients with diabetes who were treated with PPARγ agonists had not relapsed at the time of data collection,” explained Emine Atas from the Department of Biomedical Imaging and Image-guided Therapy at the varsity.

The study, published in the journal Molecular Cancer, indicates that such drugs could slow down growth of prostate cancer cells, representing a promising approach for the treatment of prostate cancer.

The researchers examined cell cultures and tissue samples from patient cohorts. They analysed how different activation states of the protein affect the cells.

Prostate cancer occurs when abnormal cells in the prostate gland grow out of control. Despite enormous medical advances in recent years, prostate cancer is the most common cancer in men, with an estimated 1.4 million diagnoses and 375,000 deaths worldwide in 2020.

The currently available treatment methods range from surgery and radiotherapy to medication. The identification of previously unknown molecular mechanisms could help to develop targeted therapies.

PPARγ, as a potential regulator of tumour growth, is a promising option that will now be investigated in further studies, said the researchers.

–IANS

rvt/

*Except for the headings & sub-headings, this story has not been edited by The enewstime.in and has been published from IANS feed.

Related Posts

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers
Health

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers

July 5, 2025
Should anti-ageing medicines be banned in India?
Health

Should anti-ageing medicines be banned in India?

July 5, 2025
Anatomy of medical college scam: Hawala deals kept bribes flowing from colleges to regulators
Health

Anatomy of medical college scam: Hawala deals kept bribes flowing from colleges to regulators

July 5, 2025
Multi-city CBI raids: Bribes, godman’s role exposed in medical college regulation; 6 held
Health

Multi-city CBI raids: Bribes, godman’s role exposed in medical college regulation; 6 held

July 5, 2025
Infections due to new Covid strains not severe, we’re monitoring: ICMR-NIV Director
Health

Infections due to new Covid strains not severe, we’re monitoring: ICMR-NIV Director

June 18, 2025
ICAR-NIHSAD Bhopal designated as containment facility for Rinderpest virus
Health

ICAR-NIHSAD Bhopal designated as containment facility for Rinderpest virus

June 16, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Resumption of FII buying hinges on India-US trade deal, Q1 results

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers

2nd Test: Had to check with Harry Brook if I was facing a hat-trick ball, reveals Jamie Smith

Should anti-ageing medicines be banned in India?

Release of Anushka Shetty, Vikram Prabhu-starrer 'Ghaati' postponed

IndusInd Bank's net advances dip nearly 4 pc in Q1, deposits also decline

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

© 2025 Designed & Developed with ❤️ by Provibe Media LLP